Flow-mediated dilatation (FMD) and prevalence of cardiovascular risk factors: The value of FMD assessment in high risk patients is limited

Kardiologia Polska

Volumn 72, Issue 3, 2014, Pages 254-261

  Mizia Stec, Katarzyna ^a   Wieczorek, Joanna ^a   Orszulak, Michał ^a   Mizia, Magdalena ^a   Gieszczyk Stroźik, Klaudia ^a   Sikora Puz, Agnieszka ^a   Haberka, Maciej ^a   Lasota, Bartosz ^a   Chmiel, Artur ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Brachial artery diameter; Cardiovascular diseases; Cardiovascular risk factors; Clinical usefulness; Endothelial dysfunction; Flow mediated dilatation

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FLOW MEDIATED DILATATION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VALVULAR HEART DISEASE; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VASODILATION;

EID: 84897126477     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2013.0316     Document Type: Article

References (29)

1. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation, 2003; 108:1772-1778. (Pubitemid 37296082)
2. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992; 340: 1111-1115.
3. Brevetti G, Silvestro A, Schiano V et al. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation, 2003; 108: 2093-2098. (Pubitemid 37337585)
4. Shimbo D, Grahame-Clarke C, Miyake Y et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis, 2007; 192: 197-203. (Pubitemid 46602298)
5. Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J, 2012; 33: 1635-1701.
6. Reiner Ž, Catapano AL, De Backer G et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818.
7. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2007; 28: 1462-1536.
8. Green DJ, Jones H, Thijssen DHJ et al. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension, 2011; 57: 363-369.
9. Thijssen DHJ, Black MA, Pyke KE et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol, 2011; 300: H2-H12.
10. Sitia S, Tomasoni L, Atzeni F et al. From endothelial dysfunction to atherosclerosis. Autoimmunity Rev, 2010; 9: 830-834.
11. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation, 1993; 88: 2149-2155. (Pubitemid 23326094)
12. Wilkinson I, Cockcroft JR. Cholesterol, lipids and arterial stiffness. Adv Cardiol, 2007; 44: 261-277. (Pubitemid 44763916)
13. Kawano H, Motoyama T, Hirashima O et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol, 1999; 34: 146-154.
14. Juonala M, Viikari JS, Ronnemaa T et al. Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young. Finns study. Hypertension, 2006; 48: 424-430. (Pubitemid 44253736)
15. Zhang X, Zhao SP, Li XP et al. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis, 2000; 149: 19-24. (Pubitemid 30125967)
16. Vita JA, Keaney JF. Endothelial function: a barometer for cardiovascular risk? Circulation, 2002; 106: 640-642. (Pubitemid 34851918)
17. Yusuf S, Hawken S, Ounpuu S et al. On behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 2004; 364: 937-952. (Pubitemid 39208455)
18. Raiko JR, Magnussen CG, Kivimäki M et al. Cardiovascular risks coresin the prediction of subclinical atherosclerosis in young adults: evidence from the cardiovascular risk in a young Finns study. Eur J Cardiovasc Prev Rehabil, 2010; 17: 549-555.
19. Witte DR, Westerink J, de Koning EJ et al. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol, 2005; 45: 1987-1993. (Pubitemid 40814119)
20. Kitta Y, Nakamura T, Kodama Y et al. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol, 2005; 46: 648-655. (Pubitemid 41132692)
21. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging, 2010; 26: 631-640.
22. Dupuis J, Tardif JC, Cernacek P et al. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation, 1999; 99: 3227-3233. (Pubitemid 29293431)
23. Gokce N, Vita JA, McDonnell M et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol, 2005; 95: 266-268. (Pubitemid 40092098)
24. Ades PA, Savage PD, Lischke S et al. The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease. Chest, 2011; 140: 1420-1427.
25. Harris RA, Nishiyama SK, Wray DW et al. Ultrasound assessment of flow-mediated dilation: a tutorial. Hypertension, 2010; 55: 1075-1085.
26. Mizia-Stec K, Gasior Z, Mizia M et al. Flow-mediated dilation and gender in patients with coronary artery disease: arterial size influences gender differences in flow-mediated dilation. Echocardiography, 2007; 24: 1051-1057. (Pubitemid 350125442)
27. Celermajer DS, Sorensen KE, Bull C et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 1994; 24: 1468-1474. (Pubitemid 24344241)
28. Otto ME, Svatikova A, Barretto RB et al. Early morning attenuation of endothelial function in healthy humans. Circulation, 2004; 109: 2507-2510. (Pubitemid 38720548)
29. Taneva E, Borucki K, Wiens L et al. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. Am J Cardiol, 2006; 97: 1002-1010.